N
XLRN

Nuveen’s Acceleron Pharma XLRN Stock Holding History

Nuveen’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-205,187
Closed -$35.3M – 3451
2021
Q3 		$35.3M Sell
205,187
-65,199
-24% -$8.53M 0.01% 883
2021
Q2 		$33.9M Sell
270,386
-1,795
-0.7% -$226K 0.01% 984
2021
Q1 		$36.9M Sell
272,181
-8,162
-3% -$1.05M 0.01% 899
2020
Q4 		$35.9M Buy
280,343
+76,766
+38% +$9M 0.01% 883
2020
Q3 		$22.9M Buy
203,577
+54,518
+37% +$5.43M 0.01% 978
2020
Q2 		$14.2M Sell
149,059
-230,040
-61% -$22.2M 0.01% 1256
2020
Q1 		$34.1M Buy
379,099
+186,736
+97% +$14.5M 0.02% 634
2019
Q4 		$10.2M Sell
192,363
-546
-0.3% -$24.9K ﹤0.01% 1581
2019
Q3 		$7.62M Sell
192,909
-1,423
-0.7% -$61.7K ﹤0.01% 1730
2019
Q2 		$7.98M Buy
+194,332
New +$8.05M ﹤0.01% 1743

Nuveen's XLRN Position: Q4 2021 in Review

Nuveen sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 205,187 shares — an estimated $35.3M sold.

Nuveen first reported a position in XLRN in Q2 2019 and held it in 10 quarters. The position peaked at $36.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Nuveen reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Nuveen sold 205,187 Acceleron Pharma shares in Q4 2021, an estimated $35.3M.
  • Nuveen first reported a position in Acceleron Pharma in Q2 2019 and held it in 10 quarters.
  • Nuveen's Acceleron Pharma position peaked at $36.9M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.